Preserving fertility in women with endometrial cancer: two clinical cases

Endometrial cancer is diagnosed increasingly in young women who wish to have children, and treatments intended to preserve fertility in these patients are becoming more common. The authors describe two women with endometrial cancer who were diagnosed and treated at our center and who needed assisted human reproductive technology, and review current knowledge based on similar cases.

Endometrial cancer; Fertility; Preservation; Assisted reproductive technology.

[1] Jemal A., Siegel R., Xu J., Ward E.: “Cancer statistics 2010”. CA Cancer J. Clin., 2010, 60, 277.

[2] Tran B.N., Connell P.P., Waggoner S., Rotmensch J., Mundt A.J.: “Characteristics and outcome of endometrial carcinoma patients age 45 years and younger”. Am. J. Clin. Oncol., 2000, 23, 476.

[3] Lee N.K., Cheung M.K., Shin J.Y., Husain A., Teng N.N., Berek J.S.: “Prognostic factors for uterine cancer in reproductive-aged women”. Obstet. Gynecol., 2007, 109, 655.

[4] Kesterson J.P., Fanning J.: “Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls”. J. Gynecol. Oncol., 2012, 23, 120.

[5] Gunderson C.C., Fader A.N., Carson K.A., Bristow R.E.: “Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review”. Gynecol. Oncol., 2012, 125, 477.

[6] Arteaga Gómez A.C., Castellanos Barroso G., Márquez Acosta G.: “Tratamiento conservador del cáncer de endometrio como una opción para preservar la fertilidad. Experiencia de cinco años en el Instituto Nacional de Perinatología Isidro Espinosa de los Reyes”. Ginecol. Obstet. Mex., 2012, 80, 394.

[7] Vasconcelos C., Felix A., Cunha T.M.: “Preoperative assessment of deep myometrial and cervical invasion in endometrial carcinoma: comparison of magnetic resonance imaging and histopathologic evaluation”. J. Obstet. Gynaecol., 2007, 27, 65.

[8] Yamazawa K., Hirai M., Fujito A., Nishi H., Terauchi F., Ishikura H., Shozu M., Isaka K.: “Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer”. Hum. Reprod., 2007, 22, 1953.

[9] Signorelli M., Caspani G., Bonazzi C., Chiappa V., Perego P., Mangioni C.: “Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases”. BJOG, 2009, 116, 114.

[10] Niwa K., Tagami K., Lian Z., Onogi K., Mori H., Tamaya T.: “Outcome of fertility-preserving treatment in young women with endometrial carcinomas”. BJOG, 2005, 112, 317.

[11] Ramirez P.T., Frumovitz M., Bodurka D.C., Sun C.C., Levenback C.: “Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review”. Gynecol Oncol., 2004, 95, 133.

[12] Baker J., Obermair A., Gebski V., Janda M.: “Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature”. Gynecol. Oncol., 2012, 125, 263.

[13] Gallos I.D., Shehmar M., Thangaratinam S., Papapostolou T.K., Coomarasamy A., Gupta J.K.: “Oral progestogensvslevonorgestrelreleasingm intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis”. Am. J. Obstet. Gynecol., 2010,

203, 547

[14] Kudesia R., Singer T., Caputo T.A., Holcomb K.M., Kligman I., Rosenwaks Z., Gupta D.: “Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma”. Am. J. Obstet. Gynecol., 2014, 210, 255.e1

[15] Kim M.K., Seong S.J., Lee T.S., Kim J.W., Nam B.H., Hong S.R., Suh K.S.: “Treatment with medroxyprogesterone acetate plus levonorgestrel- releasing intrauterine system for early-stage endometrial cancer in young women: single-arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2009)”. Jpn. J. Clin. Oncol., 2012, 42, 1215.

[16] Kim M.K., Seong S.J., Song T., Kim M.L., Yoon B.S., Jun H.S.: “Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer”. Gynecol. Oncol., 2013, 130, 470.

[17] Mazzon I., Corrado G., Masciullo V., Morricone D., Ferrandina G., Scambia G.: “Conservative surgical management of stage IA endometrial carcinoma for fertility preservation”. Fertil. Steril., 2010, 93, 1286.

[18] Laurelli G., Di Vagno G., Scaffa C., Losito S., DelGiudice M., Greggi S.: “Conservative treatment of early endometrial cancer: preliminary results of a pilot study”. Gynecol. Oncol., 2011, 120, 43.

[19] Gallo J.L., González-Paredes A., López-Criado S., López-Gallego N.F., Quiles C.: “Neoplasias primarias sincrónicas de endometrio y ovario”. Clin. Invest. Ginecol. Obstet., 2008, 35, 35.